Factors and Disparities Influencing Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists Initiation in the United States: A Scoping Review of Evidence

Factors and Disparities Influencing Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists Initiation in the United States: A Scoping Review of Evidence

Introduction: Health disparities affecting minority populations and resulting in poorer outcomes for disadvantaged groups have been documented in the literature. Sodium/glucose-cotransporter 2 (SGLT2i) inhibitors and GLP-1 receptor agonists (GLP-1RA) markedly decrease mortality from kidney and cardi...

Full description

Saved in:
Bibliographic Details
Main Authors: Josiah Moore, Ndidi Iheme, Nicholas S. Rebold, Harriet Kusi, Constance Mere, Uzoamaka Nwaogwugwu, Earl Ettienne, Weerachai Chaijamorn, Dhakrit Rungkitwattanakul
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pharmacy
Subjects:
disparity
medication
minority
initiation
Online Access:https://www.mdpi.com/2226-4787/13/2/46
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items